Prevention and management of scarring after thermal injury
Joshua Wong , Weber Lin , Jie Ding , Edward E. Tredget
Plastic and Aesthetic Research ›› 2021, Vol. 8 ›› Issue (1) : 9
Survival from burn injury has improved considerably over the past two decades such that the quality of life of the victim of thermal injuries has become a major concern. Severe proliferative scarring or hypertrophic scarring (HTS) is an all too frequent complication of burn wound healing that severely compromises quality of life for surviving burn victims. Prevention of such scarring in burn patients involves better understanding of the pathophysiology of scar formation, development of newer methods for determining depth of burn injury and earlier and advanced surgical interventions. Many established and evolving novel treatments for HTS in patients after thermal injury exist and include antifibrotic pharmaceuticals and cellular-based therapies as reviewed herein.
Thermal injury / hypertrophic scarring / transforming growth factor-β / fibrocytes / macrophages / scar prevention
| [1] |
World Health Organization. Burns: Fact sheet. Available from: https://www.who.int/en/news-room/fact-sheets/detail/burns. [Last accessed on 10 Jul 2020] |
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
Moor Instruments Inc. Early and accurate assessment of burns. Available from: http://us.moor.co.uk/product/burn-assessment-burn-assessment/286/o/41/video-channel. [Last accessed on 30 Nov 2015] |
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
| [47] |
|
| [48] |
|
| [49] |
|
| [50] |
|
| [51] |
|
| [52] |
|
| [53] |
|
| [54] |
|
| [55] |
|
| [56] |
|
| [57] |
Integra Dermal Regeneration Template [package insert on the internet]. Princeton, NJ: Integra LifeSciences; 2012. Available from: https://www.integralife.com/file/general/1453795605-1.pdf. [Last accessed on 12 Jul 2020] |
| [58] |
|
| [59] |
|
| [60] |
|
| [61] |
|
| [62] |
|
| [63] |
|
| [64] |
|
| [65] |
|
| [66] |
RD Mag (2011). Juvista Fails Late-Stage Trial. Available from: https://www.rdmag.com/news/2011/02/juvista-fails-late-stage-trial. [Last accessed on 5 Jun 2019] |
| [67] |
|
| [68] |
|
| [69] |
ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). Investigation into the Scar Reduction Potential of Prevascar (Interleukin-10). Available from: https://www.clinicaltrials.gov/ct2/show/study/NCT00984646. [Last accessed on 20 Dec 2020] |
| [70] |
|
| [71] |
|
| [72] |
|
| [73] |
|
| [74] |
|
| [75] |
|
| [76] |
|
| [77] |
|
| [78] |
|
| [79] |
|
| [80] |
|
| [81] |
|
| [82] |
|
| [83] |
|
| [84] |
|
| [85] |
|
| [86] |
|
| [87] |
|
| [88] |
|
| [89] |
|
| [90] |
|
| [91] |
|
/
| 〈 |
|
〉 |